Conventional, alternative and complementary therapies in the treatment of cancer

There’s an interesting and thought-provoking article just out in The Guardian, published in London, by an oncologist who practises in Britain’s National Health Service. It raises important questions about why some people opt for untried, untested ‘therapies’ as against trialled remedies of proven efficacy.

You can read the full article here.


New clinical trial for locally advanced or metastatic cutaneous melanoma

Cancer Support Basel was recently alerted to the fact that Merck Serono is currently recruiting volunteers who have been diagnosed with locally advanced or metastatic cutaneous melanoma.

The following link on will provide more information about this study. Also, the NCT number is NCT01693068 as a point of reference.